Vimarsana
Biggest News Aggregation in the World

Page 3 - Biologically Inspired News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biologically Inspired. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biologically Inspired Today - Breaking & Trending Today

A new control switch could make RNA therapies easier to program - Vimarsana News

A new control switch could make RNA therapies easier to program

Using an RNA sensor, MIT engineers designed a new way to trigger cells to turn on a synthetic gene. Their approach could make it possible to create targeted therapies for cancer and other diseases, by ensuring that synthetic genes are activated only in specific cells.

Source: mit.edu
4D Bioprinting Market by Type of Technology, Application Area, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Vimarsana News

4D Bioprinting Market by Type of Technology, Application Area, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

/PRNewswire/ -- The "4D Bioprinting Market by Type of Technology, Application Area, End-user and Key Geographical Regions: Industry Trends and Global...

First 'Vagina-On-A-Chip' Will Help Researchers Test Drugs - Vimarsana News

First 'Vagina-On-A-Chip' Will Help Researchers Test Drugs

A new chip re-creates the human vagina’s unique microbiome

The First 'Vagina-on-a-Chip' May Aid Researchers in Testing Drugs for Bacterial Vaginosis - Vimarsana News

The First 'Vagina-on-a-Chip' May Aid Researchers in Testing Drugs for Bacterial Vaginosis

This "vagina-on-a-chip" recreates the vaginal microbiome using live cells and bacteria to test medications against bacterial vaginosis.

EnPlusOne Biosciences on Path Towards Commercial Enzymatic RNA Synthesis - Vimarsana News

EnPlusOne Biosciences on Path Towards Commercial Enzymatic RNA Synthesis

The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.